Flotek Industries faced a major setback when its $400 million contract with the Puerto Rico Electric Power Authority was canceled after the Financial Oversight Board revoked approval and ordered termination. The contract was expected to generate significant revenue over 10 years. Following the cancellation news, Flotek's stock price plunged over 30% in three days, reflecting investor concerns about lost revenue and future prospects. Shareholders are being advised to consider legal action for potential damages and corporate reforms.
Flotek Industries faces legal action news. For readers following the Energy sector, here is Pluang's market snapshot as of Oct 21, 2026 03:42 WIB: 44 of 79 priced US Energy stocks rose today, 33 fell. Sunrun Inc (RUN) rose 10.01% to USD 7.58 with 61% sell orders, Enphase Energy Inc (ENPH) rose 5.29% to USD 32.25 with 100% sell orders, and Peabody Energy Corporation (BTU) fell 4.92% to USD 22.60. Typical hold times range from 6 to 72 days on Pluang.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
